Advertisement
Research Article| Volume 14, ISSUE 5, P281-295, October 1999

Current knowledge in the management of children and adolescents with sickle cell disease: Part 1, physiological issues

  • Kathleen Simon
    Correspondence
    Address reprint requests to Kathleen Simon, DNSc, RN, College of Nursing, Medical University of South Carolina, 99 Jonathan Lucas St., Charleston, SC 29425.
    Affiliations
    College of Nursing, Medical University of South Carolina, Charleston, SC, USA

    College of Medicine, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA
    Search for articles by this author
  • Marie L. Lobo
    Affiliations
    College of Nursing, Medical University of South Carolina, Charleston, SC, USA

    College of Medicine, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA
    Search for articles by this author
  • Sherron Jackson
    Affiliations
    College of Nursing, Medical University of South Carolina, Charleston, SC, USA

    College of Medicine, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      This article reviews the current state of the knowledge in the management of children and adolescents with sickle cell disease (SCD). Athorough review of the literature concerning physiological issues including the clinical manifestations of SCD as well as current treatment modalities is included. Therapeutic management of health and illness for a child with SCD is discussed in relation to primary, secondary, and tertiary prevention. Recommendations for nursing practice and research are made.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Adams R.J.
        Neurologic complications.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 599-621
        • Abboud M.R.
        • Jackson S.M.
        • Barredo J.
        • Beatty J.
        • Laver J.
        Bone marrow transplantation for sickle cell anemia.
        American Journal of Pediatric Hematology/Oncology. 1994; 16: 86-89
        • Achord J.L.
        Gastroenterologic and hepatobility manifestations.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 663-672
        • American Pain Society
        Principles of analgesic use in the treatment of acute pain and chronic cancer pain.
        American Pain Society, Skokie, IL1992
        • Armstrong F.D.
        • Pegelow C.H.
        • Gonzalez J.C.
        • Martinez A.
        Impact of children's sickle cell history on nurse and physician ratings of pain and medication decisions.
        Journal of Pediatric Psychology. 1992; 17: 651-664
        • Ashwill J.W.
        • Droske S.C.
        Nursing care of children: Principles and practice.
        Saunders, Philadelphia1997
        • Ballas S.K.
        Management of sickle pain.
        Current Opinion in Hematology. 1997; 4: 104-111
        • Ballas S.K.
        • Park D.
        • Wapner R.J.
        Neonatal screening for sickle cell disease in a metropolitan university hospital: Efficacy and problems.
        Journal of Medical Screening. 1994; 1: 229-232
        • Benjamin G.C.
        Sickle cell trait and sickle cell anemia: A review.
        Military Medicine. 1983; 148: 701-706
        • Benjamin L.J.
        Pain in sickle cell disease.
        in: Foley K.M. Payne R. Current therapy in pain. Decker, Toronto1989: 90-104
        • Benjamin L.J.
        Conventional and experimental approaches to the management of acute vaso-occlusive pain (painful crises).
        in: Mankad V.N. Moore R.B. Sickle cell disease: Pathophysiology, diagnosis, and management. Praeger, Westport, CT1992: 248-270
        • Berg A.O.
        Sickle cell disease: Screening, diagnosis, management, and counseling in newborns and infants. The Agency of Health Care Policy and Research.
        American Board of Family Practice. 1994; 7: 134-140
        • Betz C.L.
        • Hunsberger M.M.
        • Wright S.
        Familycentered nursing care of children.
        Saunders, Philadelphia1994
        • Beyer J.E.
        The oucher: A user's manual and technical report.
        Univeristy of Colorado, Denver, CO1989
        • Bhalla M.
        • Abboud M.R.
        • McLoud T.C.
        • Shepard J.O.
        • Munden M.M.
        • Jackson S.M.
        • Beaty J.R.
        • Laver J.H.
        Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion.
        Radiology. 1993; 187: 45-49
        • Bowden V.R.
        • Dickey S.B.
        • Greenberg C.S.
        Children and their families: Continuum of care.
        Saunders, Philadelphia1998
        • Brogdon B.G.
        • Lecklitner M.L.
        • Machen B.C.
        • Williams J.P.
        Radiological implications of sickle cell disease.
        in: Mankad V.N. Moore R.B. Sickle cell disease: Pathophysiology, diagnosis, and management. Praeger, Westport, CT1992: 321-350
        • Buchanan G.R.
        Infection.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven Press, New York1994: 567-587
      1. (Unpublished protocol)
        • Buchanan G.
        • Morrison R.
        • Vedro D.
        Criteria for assessing severity of sickle cell vaso-occlusive crisis.
        1989
        • Castro O.
        • Brambilla D.J.
        • Thorington B.
        • Reindorf C.A.
        • Scott R.B.
        • Gillette P.
        • Vera J.C.
        • Levy P.S.
        • the Cooperative Study of Sickle Cell Disease
        The acute chest syndrome in sickle cell disease: Incidence and risk factors.
        Blood. 1994; 84: 643-649
        • Charache S.
        Experimental therapy of sickle cell disease: Use of hydroxyurea.
        The American Journal of Pediatric Hematology/Oncology. 1994; 16: 62-66
        • Charache S.
        • Dover G.J.
        • Moore R.D.
        • Eckert S.
        • Ballas S.
        • Koshy M.
        • Milner P.
        • Orringer E.
        • Phillips G.
        • Platt O.
        • Thomas G.
        Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia.
        Blood. 1992; 78: 212-216
        • Charache S.
        • Dover G.J.
        • Moyer M.A.
        • Moore J.W.
        Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia.
        Blood. 1987; 69: 109-116
      2. Charache S. Lubin B. Reid C.D. Management and therapy of sickle cell disease. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Washington, DC1992
        • Cohen A.
        Iron overload.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 799-808
        • Collins A.F.
        • Fassos F.F.
        • Stobie S.
        • Lewis N.
        • Shaw D.
        • Fry M.
        • Templeton D.M.
        • McClelland R.A.
        • Koren G.
        • Olivieri N.F.
        Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxyprid-4-one (II) in iron-loaded patients with sickle cell disease.
        Blood. 1994; 83: 2329-2333
        • Committee on Genetics, American Academy of Pediatrics
        Health supervision for children with sickle cell disease and their families.
        Pediatric. 1996; 98: 467-472
        • Conner-Warren R.L.
        Pain intensity and home pain management of children with sickle cell disease.
        Issues in Comprehensive Pediatric Nursing. 1996; 19: 183-195
      3. Newborn screening for sickle cell disease and other hemoglobinopathies.
        Journal of the American Medical Association. 1987; 258 (Consensus Conference on Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies^): 1205-1209
        • Covitz W.
        Cardiac disease.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 725-734
        • Cummins D.
        • Heuschkel R.
        • Davis S.C.
        Penicillin prophylaxis in children with sickle cell disease in Brent.
        British Medical Journal. 1991; 302: 989-990
        • Davis H.
        • Gergen P.J.
        • Moore R.M.
        Geographic differences in mortality of young children with sickle cell disease in the United States.
        Public Health Reports. 1997; 112: 52-58
        • Davis H.
        • Schoendorf K.C.
        • Gergen P.J.
        • Moore R.M.
        National trends in the mortality of children with sickle cell disease, 1968 through 1992.
        American Journal of Public Health. 1997; 87: 1317-1322
        • Day S.
        • Brunson G.
        • Wang W.
        A successful education program for parents of infants with newly diagnosed sickle cell disease.
        Journal of Pediatric Nursing. 1992; 7: 52-57
        • Day S.W.
        • Brunson G.E.
        • Wang W.C.
        Successful newborn sickle cell trait counseling program using health department nurses.
        Pediatric Nursing. 1997; 23: 557-561
        • de Montalembert M.
        • Belloy M.
        • Bernaudin F.
        • Gouraud F.
        • Capdeville R.
        • Mardini R.
        • Philippe N.
        • Jais J.P.
        • Bardakdjian J.
        • Ducrocq R.
        • Maier-Redelsperger M.
        • Elion J.
        • Labie D.
        • Girot R.
        Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French study group on sickle cell disease.
        Journal of Pediatric Hematology/Oncology. 1997; 19: 313-318
        • de Montalembert M.
        • Guilloud-Bataille M.
        • Ducros A.
        • Galacteros F.
        • Girot R.
        • Herve C.
        • Maier-Redelsperger M.
        • Feingold J.
        Implications of prenatal diagnosis of sickle cell disease.
        Genetic Counseling. 1996; 7: 9-15
        • Dinges D.F.
        • Whitehouse W.G.
        • Orne E.C.
        • Bloom P.B.
        • Carlin M.M.
        • Bauer N.K.
        • Gillen K.A.
        • Shapiro B.S.
        • Ohene-Frempong K.
        • Dampier C.
        • Orne M.T.
        Self-hypnosis training as an adjunctive treatment in the management of pain associated with sickle cell disease.
        International Journal of Clinical & Experimental Hypnosis. 1997; 45: 417-432
        • Dover G.J.
        • Platt O.S.
        Sickle cell disease.
        in: Nathan D.G. Orkin S.H. Nathan and Oski's hematology of infancy and childhood. Saunders, Philadelphia1998: 762-809
        • Eland J.M.
        Children in pain.
        in: Jackson D.B. Saunders R.B. Child health nursing: A comprehensive approach to the care of children and their families. Lippincott, Philadelphia1993: 641-669
        • Falk R.J.
        • Jennette J.C.
        Renal disease.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 673-680
        • Fleming A.F.
        The presentation, management and prevention of crisis in sickle cell disease in Africa.
        Blood Reviews. 1989; 3: 18-28
        • Frush K.
        • Ware R.E.
        • Kinney T.R.
        Emergency department visits by children with sickle cell hemoglobinopathies: Factors associated with hospital admission.
        Pediatric Emergency Care. 1995; 11: 9-12
        • Fuggle P.
        • Shand P.A.X.
        • Gill L.J.
        • Davies S.C.
        Pain, quality of life, and coping in sickle cell disease.
        Archives of Disease in Childhood. 1996; 75: 199-203
        • Gaston M.H.
        • Reid C.D.
        Infection in sickle cell disease.
        in: Mankad V.N. Moore R.B. Sickle clel disease: Pathophysiology, diagnosis, and management. Praeger, Westport, CT1992: 271-299
        • Gaston M.H.
        • Verter J.I.
        • Woods G.
        • Pegelow C.
        • Kelleher J.
        • Presbury G.
        • Zarkowsky H.
        • Vichinsky E.
        • Iyer R.
        • Lobel J.S.
        • Diamond S.
        • Holbrook C.
        • Gill F.M.
        • Ritchet K.
        • Falleta J.M.
        Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial.
        New England Journal of Medicine. 1986; 314: 1593-1599
        • Gee B.E.
        • Platt O.S.
        Growth and development.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 589-597
        • Gelfand M.J.
        • Daya S.A.
        • Rucknagel D.L.
        • Kalinyak K.A.
        • Paltiel H.J.
        Simultaneous occupance of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome.
        The Journal of Nuclear Medicine. 1993; 34: 614-618
        • Gil K.M.
        • Phillips G.
        • Abrams M.R.
        • Williams D.A.
        Pain drawings and sickle cell disease.
        The Clinical Journal of Pain. 1990; 6: 105-109
        • Gil K.M.
        • Thompson R.J.
        • Keith B.R.
        • Tota-Faucette M.
        • Noll S.
        • Kinney T.R.
        Sickle cell disease pain in children and adolescents: Change in pain frequency and coping strategies over time.
        Journal of Pediatric Psychology. 1993; 18: 621-637
        • Gil K.M.
        • Williams D.A.
        • Thompson R.J.
        • Kinney T.R.
        Sickle cell disease in children and adolescents: The relation of child and parent pain coping strategies to adjustment.
        Journal of Pediatric Psychology. 1991; 16: 643-663
        • Greenberg J.
        • Ohene-Frempong K.
        • Halus J.
        • Way C.
        • Schwartz E.
        Trial of low doses of aspirin as prophylaxis in sickle cell disease.
        Journal of Pediatrics. 1983; 102: 781-784
        • Griffin T.C.
        • McIntire D.
        • Buchanan G.R.
        High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
        New England Journal of Medicine. 1994; 330: 733-737
        • Hall H.
        • Chiarucci K.
        • Berman B.
        Self-regulation and assessment approaches for vaso-occlusive pain management for pediatric sickle cell anemia patients.
        International Journal of Psychosomatics. 1992; 39: 28-33
        • Haynes J.
        • Kirkpatrick M.B.
        The acute chest syndrome of sickle cell disease.
        The American Journal of the Medical Sciences. 1993; 305: 326-330
        • Haynes J.
        • Manci E.
        • Voelkel N.
        Pulmonary complications.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 623-631
        • Hester N.K.
        The preoperational child's reaction to immunization.
        Nursing Research. 1979; 28: 250-252
        • Johnson F.L.
        • Mentzer W.C.
        • Kalinyak K.A.
        • Sullivan K.M.
        • Abboud M.R.
        Bone marrow transplantation for sickle cell disease: The United States experience.
        The American Journal of Pediatric Hematology/Oncology. 1994; 16: 22-26
        • Lane P.A.
        Sickle cell disease.
        Pediatric Clinics of North America. 1996; 43: 639-664
        • Lanzkowsky P.
        Manual of pediatric hematology and oncology.
        Churchill Livingstone, New York1995
        • Lutty G.A.
        • Goldberg M.F.
        Ophthalmologic complications.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 703-724
        • Mankad V.N.
        Sickle cell disease and other disorders of abnormal hemoglobin.
        in: Miller D.R. Baehner R.L. Blood diseases of infancy and childhood. Mosby, St. Louis1995: 415-459
        • Mankad V.N.
        • Dyken P.R.
        Neurological complications of sickle cell disease.
        in: Mankad V.N. Moore R.B. Sickle cell disease: Pathophysiology, diagnosis, and management. Praeger, Westport, CT1992: 300-306
        • Mankad V.N.
        • Yang Y.
        Hepatobiliary, renal, and pulmonary complications in sickle cell disease.
        in: Mankad V.N. Moore R.B. Sickle cell disease: Pathophysiology, diagnosis, and management. Praeger, Westport, CT1992: 307-320
        • Mentzer W.C.
        • Heller S.
        • Pearle P.R.
        • Hackney E.
        • Vichinsky E.
        Availability of related donors for bone marrow transplantation in sickle cell anemia.
        The American Journal of Pediatric Hematology/Oncology. 1994; 16: 27-29
        • Milne R.I.
        Assessment of care of children with sickle cell disease: Implications for neonatal screening programmes.
        British Medical Journal. 1990; 300: 371-374
        • Morrison R.A.
        • Vedro D.A.
        Pain management in the child with sickle cell disease.
        Pediatric Nursing. 1989; 15: 595-599
        • Morrison R.A.
        • Vedro D.A.
        Pain management in the child with sickle cell disease.
        Pediatric Nursing. 1989; 15: 613
        • Nagel R.L.
        Origins and dispersion of the sickle gene.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven Press, New York1994: 353-380
        • Ohene-Frempong K.
        • Schwartz E.
        Clinical features of thalassemia.
        Pediatric Clinics of North America. 1980; 27: 403-420
        • Ohene-Frempong K.
        • Smith-Whitley K.
        Use of hydroxyurea in children with sickle cell disease: What comes next?.
        Seminars in Hematology. 1997; 34: 30-41
        • Payne R.
        Pain management in sickle cell disease: Rationale and techniques.
        Annals of the New York Academy of Sciences. 1989; 565: 189-206
        • Pearson H.A.
        Sickle cell diseases: Diagnosis and management in infancy and childhood.
        Pediatrics in Review. 1987; 9: 121-130
        • Pegelow C.H.
        Survey of pain management therapy provided for children with sickle cell disease.
        Clinical Pediatrics. 1992; 31: 211-214
        • Pegelow C.H.
        • Adams R.J.
        • McKie V.
        • Abboud M.
        • Berman B.
        • Miller S.T.
        • Olivieri N.
        • Vichinsky E.
        • Wang W.
        • Brambilla D.
        Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions.
        Journal of Pediatrics. 1995; 126: 896-899
        • Phillips G.
        • Eckman J.R.
        • Hebbel R.P.
        Leg ulcers and myofascial syndromes.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 681-688
        • Platt O.S.
        • Thorington M.S.
        • Brambilla D.J.
        • Milner P.F.
        • Rosse W.F.
        • Vichinsky E.
        • Kinney T.R.
        Pain in sickle cell disease: Rates and risk factors.
        The New England Journal of Medicine. 1991; 325: 11-16
        • Pryle B.J.
        • Grech H.
        • Stoddart P.A.
        • Carson R.
        • O'Mahoney T.
        • Reynolds F.
        Toxicity of norpethidine in sickle cell crisis.
        British Journal of Medicine. 1992; 304: 1478-1479
        • Rogers Z.R.
        Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
        Seminars in Hematology. 1997; 34: 42-47
        • Rucknagel D.L.
        • Kalinyak K.A.
        • Gelfand M.J.
        Rib infarcts and acute chest syndrome in sickle cell diseases.
        The Lancet. 1991; 337: 831-833
        • Rudolph R.
        • Williams J.S.
        Cholecystectomy in patients with sickle cell disease: Experience at a regional hospital in southeast Georgia.
        Journal of the National Medical Association. 1992; 84: 692-696
        • Sears D.A.
        Sickle cell trait.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 381-394
        • Serjeant G.R.
        Sickle cell disease.
        Oxford University Press, Oxford1992
        • Shafer F.E.
        • Lorey F.
        • Cunningham G.C.
        • Klumpp C.
        • Vichinsky E.
        • Lubin B.
        Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program.
        Journal of Pediatric Hematology/Oncology. 1996; 18: 36-41
        • Shapiro B.S.
        The management of pain in sickle cell disease.
        Pediatric Clinics of North America. 1989; 36: 1029-2045
        • Shapiro B.S.
        • Ballas S.K.
        The acute painful episode.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 531-543
        • Shapiro B.S.
        • Benjamin L.J.
        • Payne R.
        • Heidrich G.
        Sickle cell-related pain: Perceptions of medical practitioners.
        Journal of Pain & Symptom Management. 1997; 14: 168-174
        • Shapiro B.S.
        • Cohen D.E.
        • Howe C.J.
        Patientcontrolled analgesia for sickle-cell-related pain.
        Journal of Pain and Symptom Management. 1993; 8: 22-28
        • Shapiro B.S.
        • Dinges D.F.
        • Orne E.C.
        • Bauer N.
        • Reilly L.B.
        • Whitehouse W.G.
        • Ohene-Frempong K.
        • Orne M.^.
        Home management of sickle cell-related pain in children and adolescents: Natural history and impact on school attendance.
        Pain. 1995; 61: 139-144
        • Sharpe J.N.
        • Brown R.T.
        • Thompson N.J.
        • Eckman J.
        Predictors of coping with pain in mothers and their children with sickle cell syndrome.
        Journal of the American Academy of Child and Adolescent Psychiatry. 1994; 33: 1246-1255
      4. Sickle Cell Disease Guideline Panel.
        in: Sickle cell disease: Screening, diagnosis, management, and counseling in newborns and infants. Clinical practice guideline no. 6. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD1993
        • Sporrer K.A.
        • Jackson S.M.
        • Agner A.
        • Laver J.
        • Abboud M.R.
        Pain in children and adolescents with sickle cell anemia: A prospective study utilizing self-reporting.
        The American Journal of Pediatric Hematology/Oncology. 1994; 16: 219-224
        • Styles L.A.
        • Vichinsky E.P.
        Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine.
        Journal of Pediatric Hematology/Oncology. 1996; 18: 42-45
        • Trentadue N.O.
        • Kachoyeanos M.K.
        • Lea G.
        A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.
        Journal of Pediatric Nursing. 1998; 13: 15-19
        • Tsevat J.
        • Wong J.
        • Pauker S.
        • Steinberg M.
        Neonatal screening for sickle cell disease: A cost effective analysis.
        Journal of Pediatrics. 1991; 118: 546-554
        • Varni J.W.
        • Walco G.A.
        Chronic and recurrent pain associated with pediatric chronic diseases.
        Issues in Comprehensive Pediatric Nursing. 1988; 11: 73-86
        • Vermylen C.
        • Cornu G.
        Bone marrow transplantation for sickle cell disease: The European experience.
        The American Journal of Pediatric Hematology/Oncology. 1994; 16: 18-21
        • Vichinsky E.
        Transfusion therapy.
        in: Embury S.H. Hebbel R.P. Mohandas N. Steinberg M.H. Sickle cell disease: Basic principles and clinical practice. Raven, New York1994: 781-798
        • Vichinsky E.P.
        Hydroxyurea in children: Present and future.
        Seminars in Hematology. 1997; 34: 22-29
        • Vichinsky E.P.
        • Earles A.
        • Johnson R.A.
        • Hoag M.S.
        • Williams A.
        • Lubin B.
        Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
        New England Journal of Medicine. 1990; 322: 1617-1621
        • Vichinsky E.P.
        • Styles L.A.
        • Coangelo L.H.
        • Wright E.C.
        • Castero O.
        • Nickerson B.
        Acute chest syndrome in sickle cell disease: Clinical presentation and course. Cooperative study of sickle cell disease.
        Blood. 1997; 89: 1787-1792
        • Vichinsky E.
        • Williams R.
        • Das M.
        • Earles A.N.
        • Lewis N.
        • Adler A.
        • McQuitty J.
        Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia.
        Blood. 1994; 83: 3107-3112
        • Walco G.A.
        • Dampier C.D.
        Pain in children and adolescents with sickle cell disease: A descriptive study.
        Journal of Pediatric Psychology. 1990; 15: 643-658
        • Walters M.C.
        • Patience M.
        • Leisenring W.
        • Eckman J.R.
        • Buchanan G.R.
        • Rogers Z.R.
        • Olivieri N.E.
        • Vichinsky E.
        • Davies S.C.
        • Mentzer W.C.
        • Powers D.
        • Scott J.P.
        • Bernaudin F.
        • Ohene-Frempong K.
        • Darbyshire P.J.
        • Wayne A.
        • Roberts I.A.
        • Dinndorf P.
        • Brandalise S.
        • Sanders J.E.
        • Matthews D.C.
        • Appelbaum F.R.
        • Storb R.
        • Sullivan K.M.
        Barriers to bone marrow transplantation for sickle cell anemia.
        Biology of Blood and Marrow Transplantation. 1996; 2: 100-104
        • Walters M.C.
        • Patience M.
        • Leisenring W.
        • Eckman J.R.
        • Scott J.P.
        • Mentzer W.C.
        • Davies S.C.
        • Ohene-Frempong K.
        • Bernaudin F.
        • Matthews D.C.
        • Storb R.
        • Sullivan K.M.
        Bone marrow transplantation for sickle cell disease.
        New England Journal of Medicine. 1996; 335: 369-376
        • Warth J.A.
        • Rucknagel D.L.
        Painful crisis and dense echinocytes: Effects of hydration and vasodilators.
        Progress in Clinical and Biological Research. 1987; 240: 429-449
        • West T.B.
        • West D.W.
        • Ohene-Frempong K.
        The presentation, frequency, and outcome of bacteremia among children with sickle cell disease and fever.
        Pediatric Emergency Care. 1994; 18: 141-143
        • Wong D.L.
        Whaley & Wong's nursing care of infants and children.
        Mosby, St. Louis1995
        • Wong D.
        • Baker C.
        Pain in children: Comparison of assessment scales.
        Pediatric Nursing. 1988; 14: 9-17
        • Wood G.M.
        • Jorgensen J.H.
        • Waclawiw M.A.
        • Reid C.
        • Wang W.
        • Pegelow C.H.
        • Rogers Z.R.
        • Iyer R.V.
        • Holbrook C.T.
        • Kinney T.R.
        • Vichinsky E.
        • Debaun M.R.
        • Grossman N.J.
        • Thomas M.D.
        • Falletta J.M.
        Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The ancillary nasopharyngeal culture study of prophylactic penicillin study II.
        Journal of Pediatric Hematology/Oncology. 1997; 19: 327-333
        • Wright L.
        • Brown A.
        • Davidson-Mundt A.
        Newborn screening: The miracle and the challenge.
        Journal of Pediatric Nursing. 1992; 7: 26-42
        • Wright S.W.
        • Zeldin M.H.
        • Wrenn K.
        • Miller O.
        Screening for sickle-cell trait in the emergency department.
        Journal of General Internal Medicine. 1994; 9: 421-424
        • Yang Y.
        • Brigham S.
        • Liu P.
        Diagnosis of sickle cell disease and its related hemoglobin disorders.
        in: Mankad V.N. Moore R.B. Sickle cell disease: Pathophysiology, diagnosis, and management. Praeger, Westport, CT1992: 201-220